Alnylam – Grants and Giving Program
Educational Grants, Sponsorships, Collaborations, and Charitable Donations Supporting Healthcare Education and Patient Health
Alnylam’s Grants and Giving program supports innovative, high-quality initiatives that provide healthcare professionals and patients with evidence-based, clinically relevant education and help improve patient health. Funding is available for eligible organizations whose work aligns with Alnylam’s disease areas of interest, including Transthyretin-mediated Amyloidosis, Acute Hepatic Porphyria, and Primary Hyperoxaluria Type 1.
Organization: Alnylam
Support Type: Educational grants, sponsorships, collaborations, and charitable donations
Geographic Focus: Not limited to one geography; eligible organizations should review Alnylam’s portal and program guidance
Deadline: Rolling for sponsorships, charitable donations, and collaborations; educational grants are reviewed monthly. Requests must be submitted at least 45 days before the activity or program start date.
New to corporate grant fundraising?
Read our Corporate Grants for Nonprofits: Ultimate Guide to learn how corporate funding works.
About the Funder
Alnylam is a biopharmaceutical company focused on RNA interference therapeutics. Through its Grants and Giving Office, Alnylam supports independent education, charitable initiatives, sponsorships, and collaborative activities that advance science, healthcare, patient education, and community needs connected to its areas of focus.
What This Program Supports
Alnylam considers funding requests for initiatives that support healthcare education, patient health, scientific knowledge, and relevant community needs. Projects should align with Alnylam’s disease areas of interest and may focus on education, unmet needs, improving standards of care, ongoing research awareness, or other appropriate healthcare-related purposes.
Disease Areas of Interest
Transthyretin-mediated Amyloidosis
Also referred to as ATTR amyloidosis.
Acute Hepatic Porphyria
Also referred to as AHP.
Primary Hyperoxaluria Type 1
Also referred to as PH1.
Funding Types
Educational Grants — CME
Support for educational activities developed and executed by independent third parties to maintain, develop, or increase the knowledge, skills, and professional performance of healthcare professionals.
Educational Grants — Non-CME
Support provided to third-party organizations for educational activities that deliver scientific, clinical, or medical information with the goal of improving patient care or providing a service to patients.
Sponsorships
Support for events, projects, or initiatives aimed at educating patients, caregivers, scientists, or healthcare professionals where Alnylam receives a tangible benefit. Examples may include corporate memberships, patient advocacy conference support, advertising opportunities, exhibition booths, or satellite symposium time slots.
Collaborations
Activities or projects undertaken by Alnylam and one or more external organizations where each party contributes expertise, services, or other meaningful involvement.
Charitable Donations
Monetary or in-kind support to registered charitable organizations to advance science, healthcare, education, or other genuine charitable purposes. Charitable donations may support philanthropic initiatives or general purposes aligned with the organization’s mission.
Eligible Support Types
Educational grants for CME activities
Educational grants for non-CME education
Sponsorship support for eligible events, programs, or projects
Collaborative activities with external organizations
Charitable donations to registered charitable organizations
Monetary or in-kind charitable support
Eligibility & Preferences
Support may only be provided to eligible organizations or entities. Individual recipients may not apply for or receive funding.
Applicants must submit requests electronically through Alnylam’s funding portal, which is in English. Organizations that have difficulty submitting in English may contact the Grants and Giving Office for guidance.
Applicants should be prepared to provide valid, government-issued proof of tax status.
Requests should:
Align with Alnylam’s disease areas of interest
Support education, patient care, scientific knowledge, or relevant community needs
Be submitted by an eligible organization or entity
Comply with all applicable legal and regulatory requirements
Be submitted at least 45 days before the activity or program start date
Ineligible Requests
Alnylam does not provide funding directly to individuals. Support may only be awarded to eligible organizations or entities.
Requests that do not align with Alnylam’s disease areas of interest, legal and regulatory requirements, or funding category guidelines may not be approved. Alnylam also notes that not every request can be funded, and some approved requests may be funded at a lower amount than requested.
Funding Amounts
Alnylam does not publish standard award amounts for its Grants and Giving program. Funding levels may vary based on the type of request, program alignment, available resources, review outcomes, and the amount requested.
Timeline & Review
📅 Educational Grants: Reviewed through a formal monthly process
📅 Sponsorships: Reviewed on a rolling basis
📅 Charitable Donations: Reviewed on a rolling basis
📅 Collaborations: Reviewed on a rolling basis
📅 Minimum Lead Time: Requests must be submitted at least 45 days before the activity or program start date
📅 Decision Notification: Funding decisions are communicated by email through the electronic portal
📅 Final Approval: Funding is not final until a Letter of Agreement is executed with Alnylam
Application / Request Process
Applicants must submit funding requests electronically through Alnylam’s funding portal. The submission should be made in English unless the applicant contacts Alnylam for guidance.
The process includes:
1. Submission
Organizations submit the request through Alnylam’s online funding portal. The request must be submitted at least 45 days before the start date of the activity or program.
2. Review
If a request is incomplete or additional information is needed, Alnylam’s Grants and Giving Office will contact the applicant. CME and non-CME educational grants are reviewed monthly by the Alnylam Grant Review Committee. Sponsorships, charitable donations, and collaborations are reviewed on a rolling basis.
3. Notification
Funding decisions are communicated by email through the electronic portal.
4. Agreement
Funding requests are not considered final until a Letter of Agreement has been executed with Alnylam.
5. Reconciliation for Educational Grants
For CME and non-CME educational grants, grant reconciliation must be completed within 90 days of the activity or program end date. Unused funds must be returned to Alnylam.
Apply / Learn More:
➡️ Alnylam Grants and Giving
➡️ Submit a Request for Support
➡️ Email questions about educational grants to grants@alnylam.com
➡️ Email questions about charitable donations to CSR@alnylam.com
Why This Opportunity Is a Good Fit
This opportunity is a strong fit for eligible organizations that:
Provide healthcare education for professionals, patients, caregivers, or the broader healthcare community
Work in Alnylam’s disease areas of interest, including ATTR amyloidosis, AHP, or PH1
Develop evidence-based, clinically relevant, or performance-based education
Address unmet needs or help improve standards of patient care
Seek sponsorship support for educational events or projects where tangible benefits are provided
Are registered charitable organizations advancing science, healthcare, education, or related charitable purposes
Can submit a complete request at least 45 days before the activity or program start date
Alnylam’s Grants and Giving program is best suited for healthcare, patient advocacy, scientific, educational, and charitable organizations with strong alignment to Alnylam’s therapeutic areas and a clear plan for improving education, care, or community benefit.
Corporate Grants Guide Notes
Review Type: Monthly review for educational grants; rolling review for sponsorships, charitable donations, and collaborations
Deadline: Rolling, with a minimum 45-day lead time before the activity or program start date
Support Type: Educational grants, sponsorships, collaborations, and charitable donations
Funding Amount: Not published
Best Suited For: Healthcare education providers, patient advocacy organizations, scientific and medical education organizations, and registered charitable organizations aligned with Alnylam’s disease areas of interest
